雑誌文献を検索します。書籍を検索する際には「書籍検索」を選択してください。

検索

書誌情報 詳細検索 by 医中誌

Japanese

Late-Onset Dyskinesia Occurring During Antipsychotic Treatment for Schizophrenia: Management of Tardive Dyskinesia Based on the Latest Knowledge Mayumi Sakata 1 , Hidefumi Ito 1 1Department of Neurology, Wakayama Medical University Keyword: 遅発性ジスキネジア , 統合失調症 , ドパミン受容体遮断薬 , 小胞モノアミン輸送体2選択的阻害薬 , 淡蒼球内節脳深部刺激療法 , Gpi-DBS , tardive dyskinesia , schizophrenia , dopamine receptor blocking agents , vesicular monoamine transporter 2 selective inhibitor pp.571-574
Published Date 2022/5/1
DOI https://doi.org/10.11477/mf.1416202082
  • Abstract
  • Look Inside
  • Reference

Abstract

Tardive dyskinesia is a drug-induced involuntary movement related to long-term use of dopamine receptor-blocking agents. If there is no improvement upon discontinuation or change in the causative drug, treatment needs to be initiated. The most effective drug is the vesicular monoamine transporter 2 selective inhibitor. Other drugs, such as clonazepam, amantadine, yokukansan, and Ginkgo biloba extract, may be effective in some patients. Botulinum toxin treatment and deep brain stimulation are potential treatment options for patients with tardive dyskinesia that is refractory to the aforementioned agents. Optimal treatment should be selected while monitoring for mental illnesses.


Copyright © 2022, Igaku-Shoin Ltd. All rights reserved.

基本情報

電子版ISSN 1344-8129 印刷版ISSN 1881-6096 医学書院

関連文献

もっと見る

文献を共有